Porter CC - Search Results

1

Targeting developmental pathways in children with cancer: what price success?

Gore L, DeGregori J, Porter CC. Gore L, et al. Among authors: porter cc. Lancet Oncol. 2013 Feb;14(2):e70-8. doi: 10.1016/S1470-2045(12)70530-2. Lancet Oncol. 2013. PMID: 23369685 Free PMC article. Review.

2

Impaired DNA replication within progenitor cell pools promotes leukemogenesis.

Bilousova G, Marusyk A, Porter CC, Cardiff RD, DeGregori J. Bilousova G, et al. Among authors: porter cc. PLoS Biol. 2005 Dec;3(12):e401. doi: 10.1371/journal.pbio.0030401. Epub 2005 Nov 15. PLoS Biol. 2005. PMID: 16277552 Free PMC article.

3

Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.

Porter CC, DeGregori J. Porter CC, et al. Blood. 2008 Dec 1;112(12):4466-74. doi: 10.1182/blood-2008-03-146571. Epub 2008 Jun 27. Blood. 2008. PMID: 18587011 Free PMC article.

4

Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A.

Schlegel J, Redzic JS, Porter CC, Yurchenko V, Bukrinsky M, Labeikovsky W, Armstrong GS, Zhang F, Isern NG, DeGregori J, Hodges R, Eisenmesser EZ. Schlegel J, et al. Among authors: porter cc. J Mol Biol. 2009 Aug 21;391(3):518-35. doi: 10.1016/j.jmb.2009.05.080. Epub 2009 Jun 3. J Mol Biol. 2009. PMID: 19500591 Free PMC article.

5

Irradiation selects for p53-deficient hematopoietic progenitors.

Marusyk A, Porter CC, Zaberezhnyy V, DeGregori J. Marusyk A, et al. Among authors: porter cc. PLoS Biol. 2010 Mar 2;8(3):e1000324. doi: 10.1371/journal.pbio.1000324. PLoS Biol. 2010. PMID: 20208998 Free PMC article.

6

Relative fitness of hematopoietic progenitors influences leukemia progression.

Porter CC, Baturin D, Choudhary R, DeGregori J. Porter CC, et al. Leukemia. 2011 May;25(5):891-5. doi: 10.1038/leu.2011.22. Epub 2011 Feb 18. Leukemia. 2011. PMID: 21331070 Free PMC article. No abstract available.

7

Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.

Porter CC, Kim J, Fosmire S, Gearheart CM, van Linden A, Baturin D, Zaberezhnyy V, Patel PR, Gao D, Tan AC, DeGregori J. Porter CC, et al. Leukemia. 2012 Jun;26(6):1266-76. doi: 10.1038/leu.2011.392. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289989 Free PMC article.

8

ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53.

Sullivan KD, Padilla-Just N, Henry RE, Porter CC, Kim J, Tentler JJ, Eckhardt SG, Tan AC, DeGregori J, Espinosa JM. Sullivan KD, et al. Among authors: porter cc. Nat Chem Biol. 2012 Jul;8(7):646-54. doi: 10.1038/nchembio.965. Epub 2012 Jun 3. Nat Chem Biol. 2012. PMID: 22660439 Free PMC article.

9

Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.

Casás-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, Scarborough HA, Bunn PA Jr, Chan DC, Tan AC, DeGregori J. Casás-Selves M, et al. Among authors: porter cc. Cancer Res. 2012 Aug 15;72(16):4154-64. doi: 10.1158/0008-5472.CAN-11-2848. Epub 2012 Jun 27. Cancer Res. 2012. PMID: 22738915 Free PMC article.

10

Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.

Gardner LA, Klawitter J, Gregory MA, Zaberezhnyy V, Baturin D, Pollyea DA, Takebe N, Christians U, Gore L, DeGregori J, Porter CC. Gardner LA, et al. Among authors: porter cc. Am J Hematol. 2014 Sep;89(9):896-903. doi: 10.1002/ajh.23776. Epub 2014 Jun 19. Am J Hematol. 2014. PMID: 24891015 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters